Loading... Please wait...

Call 408-734-3800 / Toll Free 877-272-7241


Partial List of Speakers (2017)

Duu-Gong Wu, Ph.D.
Former Deputy Division Director, CDER, FDA, USA
Dana Ault-Riche, Ph.D.
Co-Founder and CEO, Reflexion Pharmaceuticals, USA
David Lin, Ph.D.
Senior consultant, Former Acting Deputy Division Director, CDER, FDA Biologics Consulting Group, USA
Christopher A. Rhodes, Ph.D.
President and CEO, President of Boulder Peptide Symposium, Drug Delivery Experts, USA
Anthony Partridge Ph.D.
Principal Scientist, Merck, USA
Soumitra Ghosh, Ph.D.
Co-founder and CSO, President of Peptide Therapeutic Foundation, Avexegen Therapeutics, USA
Richard Pittner, Ph.D.
Co-Founder, OXT Therapeutics and BioShore Partners, USA
Ranjan Chakrabarti, Ph.D.
Vice President and Global Head of Biologics Lab Operations, USP, USA
Zhaohui (Zoe) Wang, Ph.D.
J.D., Partner, Co-head of patent practice group, JunHe, China and USA

Peptide Therapeutics Talks

talk peptide therapeutic development

Talks and discussions covering the development of peptide therapeutics are key parts to our symposium. In addition, we hold special panels covering topics that include regulatory affairs, quality assurance, and venture capitial investments. The panels feature discussions from FDA, CFDA and USP experts on evolving regulatory environments in the pharmaceutical industry.